- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Lysosomotropic agents as HCV entry inhibitors ; volume:8 ; number:1 ; day:12 ; month:4 ; year:2011 ; pages:1-6 ; date:12.2011
Virology journal ; 8, Heft 1 (12.4.2011), 1-6, 12.2011
- Creator
-
Ashfaq, Usman A.
- Contributor
-
Javed, Tariq
Rehman, Sidra
Nawaz, Zafar
Riazuddin, Sheikh
SpringerLink (Online service)
- DOI
-
10.1186/1743-422X-8-163
- URN
-
urn:nbn:de:1111-201605015521
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:01 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ashfaq, Usman A.
- Javed, Tariq
- Rehman, Sidra
- Nawaz, Zafar
- Riazuddin, Sheikh
- SpringerLink (Online service)
Other Objects (12)
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
New anti-HCV agents in the pipeline
Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
Decoding hepatitis C virus entry : structural and functional determinants of the HCV entry factor CD81
Synthesis of HCV Protease Inhibitor MK-6325
Entry inhibitors in HIV therapy
Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents
Selective inhibitors of cGMP phosphodiesterases as procognitive agents
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy
Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
Untersuchung visueller Aufmerksamkeitsparameter vor und nach einer Hepatitis C (HCV)-Therapie mit Direct Antiviral Agents bei HCV-monoinfizierten und HCV/HIV-koinfizierten Patienten
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
New anti-HCV agents in the pipeline
Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
Decoding hepatitis C virus entry : structural and functional determinants of the HCV entry factor CD81
Synthesis of HCV Protease Inhibitor MK-6325
Entry inhibitors in HIV therapy
Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents
Selective inhibitors of cGMP phosphodiesterases as procognitive agents
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy
Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission
Untersuchung visueller Aufmerksamkeitsparameter vor und nach einer Hepatitis C (HCV)-Therapie mit Direct Antiviral Agents bei HCV-monoinfizierten und HCV/HIV-koinfizierten Patienten
Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies
New anti-HCV agents in the pipeline
Implications of hcv natural genetic diversity on HCV NS5B inhibitor NM283
Decoding hepatitis C virus entry : structural and functional determinants of the HCV entry factor CD81
Synthesis of HCV Protease Inhibitor MK-6325
Entry inhibitors in HIV therapy
Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
Novel heteroaryl phosphonicdiamides PTPs inhibitors as anti-hyperglycemic agents
Selective inhibitors of cGMP phosphodiesterases as procognitive agents
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy
Entry inhibitors as topical microbicides to prevent HIV-1 sexual transmission